CONDORELLI, Gianluigi
 Distribuzione geografica
Continente #
NA - Nord America 11.607
AS - Asia 7.133
EU - Europa 2.133
SA - Sud America 1.406
AF - Africa 358
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 8
Totale 22.654
Nazione #
US - Stati Uniti d'America 11.404
SG - Singapore 4.540
BR - Brasile 1.191
CN - Cina 1.086
VN - Vietnam 681
FI - Finlandia 427
IE - Irlanda 344
DE - Germania 244
IT - Italia 242
NG - Nigeria 241
HK - Hong Kong 200
FR - Francia 176
GB - Regno Unito 155
IN - India 146
SE - Svezia 111
NL - Olanda 109
CA - Canada 89
AR - Argentina 88
RU - Federazione Russa 76
BD - Bangladesh 72
MX - Messico 64
IQ - Iraq 63
TR - Turchia 47
JP - Giappone 45
BE - Belgio 40
PL - Polonia 30
EC - Ecuador 29
ZA - Sudafrica 29
ID - Indonesia 28
IL - Israele 28
CZ - Repubblica Ceca 26
ES - Italia 25
PK - Pakistan 25
UA - Ucraina 25
MA - Marocco 22
CL - Cile 21
CO - Colombia 21
VE - Venezuela 21
SA - Arabia Saudita 20
UZ - Uzbekistan 16
PH - Filippine 15
EG - Egitto 14
JO - Giordania 14
AE - Emirati Arabi Uniti 13
PY - Paraguay 13
DZ - Algeria 12
KE - Kenya 12
AZ - Azerbaigian 11
KR - Corea 11
RO - Romania 11
AT - Austria 10
GR - Grecia 10
JM - Giamaica 10
UY - Uruguay 9
ET - Etiopia 8
PE - Perù 8
CR - Costa Rica 7
HN - Honduras 7
LT - Lituania 7
MY - Malesia 7
PT - Portogallo 7
TH - Thailandia 7
AU - Australia 6
BB - Barbados 6
BG - Bulgaria 6
GE - Georgia 6
BY - Bielorussia 5
CH - Svizzera 5
HR - Croazia 5
MD - Moldavia 5
NO - Norvegia 5
NP - Nepal 5
OM - Oman 5
TN - Tunisia 5
TW - Taiwan 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AL - Albania 4
AM - Armenia 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
EE - Estonia 4
IR - Iran 4
KG - Kirghizistan 4
RS - Serbia 4
SN - Senegal 4
TT - Trinidad e Tobago 4
BN - Brunei Darussalam 3
CG - Congo 3
CU - Cuba 3
DK - Danimarca 3
HU - Ungheria 3
LK - Sri Lanka 3
LY - Libia 3
MN - Mongolia 3
SK - Slovacchia (Repubblica Slovacca) 3
GA - Gabon 2
KH - Cambogia 2
KZ - Kazakistan 2
LB - Libano 2
LV - Lettonia 2
Totale 22.620
Città #
Singapore 2.044
Chandler 1.715
Wilmington 1.488
The Dalles 761
Ashburn 701
Shanghai 560
San Mateo 550
San Jose 492
Ann Arbor 473
Helsinki 425
Dallas 374
Boardman 373
New York 359
Dublin 341
Leawood 248
Lawrence 241
Princeton 241
Benin City 240
Ho Chi Minh City 218
Beijing 199
Hong Kong 191
Hanoi 175
Woodbridge 133
Fairfield 126
Paris 122
Los Angeles 103
São Paulo 100
Amsterdam 90
Columbus 77
Milan 74
London 64
Pune 62
Council Bluffs 61
Seattle 61
San Diego 50
Santa Clara 45
Rio de Janeiro 41
Brussels 39
Falkenstein 39
Toronto 39
Tokyo 34
Orem 32
Da Nang 31
Moscow 30
Haiphong 29
Norwalk 29
Phoenix 28
Baghdad 27
Munich 27
Warsaw 26
Falls Church 25
Naples 25
Brasília 24
Chennai 23
Montreal 22
Abbiategrasso 21
Curitiba 21
Belo Horizonte 20
Mexico City 20
Stockholm 19
Brooklyn 18
Johannesburg 18
Brno 17
Campinas 17
Chicago 17
Dhaka 16
Tashkent 16
Boston 15
San Francisco 15
Frankfurt am Main 14
Porto Alegre 14
Houston 13
Jakarta 13
Ribeirão Preto 13
Fortaleza 12
Guayaquil 12
Atlanta 11
Baku 11
Hillsboro 11
Hải Dương 11
Kocaeli 11
Nairobi 11
Amman 10
Denver 10
Quito 10
Salvador 10
Biên Hòa 9
Bogotá 9
Buffalo 9
Des Moines 9
Hortolândia 9
Kingston 9
Manchester 9
New Delhi 9
Reston 9
Riyadh 9
Vũng Tàu 9
Can Tho 8
Dubai 8
Edinburgh 8
Totale 14.717
Nome #
Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis. 121
Direct oral anticoagulants in addition to antiplatelet therapy for secondary prevention after acute coronary syndromes: an updated systematic review and meta-analysis 120
RNA (Epi)genetics in cardiovascular diseases 119
TGFβ triggers miR-143/145 transfer from smooth muscle cells to endothelial cells, thereby modulating vessel stabilization 114
Endovascular treatment vs. intravenous thrombolysis alone for ischaemic stroke: a meta-analysis of randomised controlled trials 110
A G613A missense in the Hutchinson's progeria lamin A/C gene causes a lone, autosomal dominant atrioventricular block. 109
Coral Reef Aorta: A Rare Occlusive Disease of the Aorta Complicating Decision Making for Severe Aortic Stenosis Treatment. 108
Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: Effects on blood pressure control and mortality 107
[Continuity of care in heart failure: pilot study of the Tuscany region]. 106
miR-128-3p is a novel regulator of vascular smooth muscle cell phenotypic switch and vascular diseases 105
Dual Antiplatelet Therapy Continuation Beyond 1 Year After Drug-Eluting Stents: A Meta-Analysis of Randomized Trials 105
Hypoglycemia and hyperglycemia are risk factors for falls in the hospital population 105
MicroRNAs and cardiac pathology 104
Adeno-associated virus-mediated CASQ2 delivery rescues phenotypic alterations in a patient-specific model of recessive catecholaminergic polymorphic ventricular tachycardia 104
Akt mediates the cross-talk between beta-adrenergic and insulin receptors in neonatal cardiomyocytes 103
Circulating biomarkers and cardiac function over 3 years after chemotherapy with anthracyclines: the ICOS-ONE trial 103
DNA hydroxymethylation controls cardiomyocyte gene expression in development and hypertrophy 102
Adenovirus-mediated gene transfer of the retinoblastoma family member p130/RB2 blocks restenosis after endothelial injury 100
T cell costimulation blockade blunts pressure overload-induced heart failure 99
Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19 99
Epigenetic modifications and noncoding RNAs in cardiac hypertrophy and failure 98
The B subunit of the CAAT-binding factor NFY binds the central segment of the co-activator p300 97
Adenoviral gene transfer of Akt enhances myocardial contractility and intracellular calcium handling 97
Therapeutic use of microRNAs in myocardial diseases 95
Defining circulating mononuclear cells in heart failure through single-cell RNA sequencing: new insights for an old disease 95
A risk score based on baseline risk factors for predicting mortality in COVID-19 patients 95
Clinical relevance of clonal hematopoiesis in persons aged ≥80 years 95
Cardioprotection with nebivolol in patients undergoing anthracyclines: a randomized placebo-controlled trial 93
Epigenetics : a new mechanism of regulation of heart failure? 93
Critical Organizational Issues for Cardiologists in the COVID-19 Outbreak: A Frontline Experience From Milan, Italy 93
Electroactive polyurethane/siloxane derived from castor oil as a versatile cardiac patch, part II: HL-1 cytocompatibility and electrical characterizations 92
Genome-wide analysis of histone marks identifying an epigenetic signature of promoters and enhancers underlying cardiac hypertrophy 92
mTOR regulates brain morphogenesis by mediating GSK3 signaling. 91
Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy 91
Akt regulates L-type Ca2+ channel activity by modulating Cavalpha1 protein stability 91
Activation of cAMP-PKA signalling in vivo inhibits smooth muscle cell proliferation after vascular injury 91
UHRF1 epigenetically orchestrates smooth muscle cell plasticity in arterial disease 91
Aerobic interval training enhances cardiomyocyte contractility and Ca2+ cycling by phosphorylation of CaMKII and Thr-17 phospholamban 90
Dr. John Ross Jr. 90
Opposing roles of Akt and STAT3 in protection of the maternal heart from peripartum stress 90
Differential expression and functional role of GATA-2, NF-E2 and GATA-1 in normal adult erythropoiesis 89
Association of FOXO3A locus with extreme longevity in the Southern Italian Centenarian Study 88
Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice 88
Inhalation Therapy Delivers Nanoparticle-Based Therapeutic Biomolecules To The Diseased Heart 88
The possible role of chromosome X variability in hypertensive familiarity. 88
P2Y12 Inhibitors Monotherapy in Patients Undergoing Complex vs Non-Complex Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Trials 87
Antiphosphotyrosine recovery of an isulin-stimulated receptor phosphatase activity in FRTL5 cells 87
Exercise training reverses myocardial dysfunction induced by CaMKIIδC overexpression by restoring Ca2+ homeostasis. 87
Mutated p21/WAF/CIP transgene overstatement reduces smooth muscle cell proliferation, macrophage deposition, oxidation-sensitive mechanisms, and restenosis in hypercholesterolemic apolipoprotein E knockout mice 87
Interleukin-6 Trans-Signaling and Risk of Future Cardiovascular Events: A New Avenue for Atheroprotection? 87
MicroRNAs in cardiovascular biology and heart disease 87
Circ_Lrp6, a Circular RNA Enriched in Vascular Smooth Muscle Cells, Acts as a Sponge Regulating miRNA-145 Function 87
Electroactive polyurethane/siloxane derived from castor oil as a versatile cardiac patch, part I: Synthesis, characterization,and myoblast proliferation and differentiation 87
Abnormal responses to saline load in hypertensive patients with parental history of cardiovascular accidents 87
Adult c-kit(pos) cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair 87
Histone Methyltransferase G9a Is Required for Cardiomyocyte Homeostasis and Hypertrophy. 87
RBP and microRNA control of endothelial cell function 86
T Cell Costimulation Blockade Blunts Age-Related Heart Failure 86
Association Between Colchicine Treatment and Clinical Outcomes in Patients with Coronary Artery Disease: Systematic Review and Meta-analysis 85
Translating cardioprotection for patient benefit : position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology 85
Single-Cell Sequencing of Mouse Heart Immune Infiltrate in Pressure Overload-Driven Heart Failure Reveals Extent of Immune Activation 85
Radial Versus Femoral Access for Coronary Interventions Across the Entire Spectrum of Patients With Coronary Artery Disease: A Meta-Analysis of Randomized Trials 85
The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease 84
A pentamer transcriptional complex including tal-1 and retinoblastoma protein downmodulates c-kit expression in normal erythroblasts 84
A Nitric Oxide-releasing Derivative of Enalapril, NCX-899, Prevents Progressive LV Dysfunction and Improves Remodeling in Cardiomyopathic Hamsters with Heart Failure 83
MicroRNAs as Companion Biomarkers for the Diagnosis and Prognosis of Acute Coronary Syndromes 83
p300/CBP modulates co-operation between MEF2A and TR/RxR 83
Uses and compositions comprising mirnas 83
The emerging role of microRNAs in cardiovascular biology 82
Circulating microRNAs and aerobic fitness : the HUNT-study 82
Genetic variants in CCNB1 associated with differential gene transcription and risk of coronary in-stent restenosis 82
Inhibition of Class I Histone Deacetylase with an Apicidine Derivative Prevents Cardiac Hypertrophy and Failure 82
An autofluorescence-based method for the isolation of highly purified ventricular cardiomyocytes 82
Development and validation of a risk score using complete blood count to predict in-hospital mortality in COVID-19 patients 82
Coronary Artery Dissection in Drug-Coated Balloon Angioplasty: Incidence, Predictors, and Clinical Outcomes 82
Deciphering the beta-adrenergic response in human embryonic stem cell-derived-cardiac myocytes: closer to clinical use? 81
The long noncoding RNA landscape in cardiovascular disease: a brief update. 81
Physiological myocardial hypertrophy: how and why? 81
Akt increases sarcoplasmic reticulum Ca2+ cycling by direct phosphorylation of phospholamban at Thr17 81
The cdc2-related kinase, PISSLRE, is essential for cell growth and acts in G2 phase of the cell cycle 80
Epigenetics in heart failure 80
Endoplasmic reticulum stress at the crossroads of progeria and atherosclerosis 80
MicroRNAs in cardiovascular disease: an introduction for clinicians 80
p130/pRb2 has a similar yet distinctive growth suppressive properties as retinoblastoma family members, pRb and p107 79
Chemerin processing in the myocardium: A mechanism in search of a function 79
ST-Elevation Myocardial Infarction in Patients with COVID-19: Clinical and Angiographic Outcomes 79
Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy 79
MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts 78
MiR-133a regulates collagen 1A1: potential role of miR-133a in myocardial fibrosis in angiotensin II-dependent hypertension 78
MicroRNA-134 as a potential plasma biomarker for the diagnosis of acute pulmonary embolism 78
Characterization of Myocardial Injury in Patients With COVID-19 78
Molecular determinants of the physiological adaptation to stress in the cardiomyocyte: a focus on AKT 77
IkappaB kinase epsilon and TANK-binding kinase 1 activate AKT by direct phosphorylation 77
Evidence for oxidative activation of c-Myc-dependent nuclear signaling in human coronary SMC and in early lesions of WHHL rabbits: protective effects of vitamin E 77
Regulation of cell size and contractile function by AKT in cardiomyocytes 77
Prolonged duration of myocardial ischemia in patients with coronary artery disease and impaires cardiopulmonary baroreceptor sensitivity 76
Akt1 gene transfer to the endothelium corrects impaired endothelial dependent vasorelaxation in hypertensive rats 76
SOCS1 gene transfer accelerates the transition to heart failure through the inhibition of the gp130/JAK/STAT pathway 76
Reply to letter to the editor by Bonaventura et al 76
Stem cells for cardiomyocyte regeneration: state of the art 75
Totale 8.946
Categoria #
all - tutte 147.133
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 147.133


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021626 0 0 0 0 0 0 0 0 0 355 11 260
2021/20221.206 31 20 20 315 20 18 42 201 102 91 245 101
2022/20234.485 544 116 346 553 500 398 4 419 839 394 300 72
2023/20242.520 213 245 550 147 78 358 141 149 41 63 174 361
2024/20254.226 140 89 71 96 188 481 298 501 525 923 489 425
2025/20267.794 1.381 491 385 671 306 414 2.752 486 500 408 0 0
Totale 22.880